Home / Generics
Generics
News
Sanofi fined for discouraging generic clopidogrel prescriptions
posted 17/05/2013
On 14 May 2013, French drugmaker sanofi-aventis was fined Euros 40.6 million by the French competition authority (L’Autorité... 
FDA rejects Endo petition to stop Opana ER generics
posted 17/05/2013
On 10 May 2013, FDA announced that it had rejected a petition by Endo Pharmaceuticals (Endo) to stop generics of its powerful... 
Actavis makes agreement for generic abuse-deterrent oxycodone
posted 03/05/2013
US generics maker Actavis (formerly Watson) announced on 26 April 2013 that it had reached an agreement with Purdue Pharma (P... 
Daiichi Sankyo and Ranbaxy announce synergy in Brazil
posted 29/04/2013
India-based Ranbaxy Laboratories (Ranbaxy) and its Japanese parent company Daiichi Sankyo announced on 17 April 2013 plans to... 
Mylan gains approval for generic of Valeant’s Zovirax
posted 29/04/2013
Generics giant Mylan announced on 3 April 2013 that its subsidiary Mylan Pharmaceuticals had received final approval from FDA... |
Research
Innovation in the generics industry
posted 10/05/2013
The decrease in innovation in the originator pharmaceutical industry is leading to an increase in innovation in the generics... 
Quality of generics in South Africa
posted 30/04/2013
A study of the quality of generic medicines in South Africa has shown large differences in the perception and the actual qual... 
Cost savings from use of generic medicines in Ireland
posted 12/04/2013
Ireland has one of the lowest usages of generics in the EU. However, in order to try to address this, the country introduced... 
Use of generic medicines in Ireland
posted 12/04/2013
Ireland’s Department of Health and Children intends to introduce a system of reference pricing and generics substitution in I... 
Changes in risperidone use in Austria after introduction of generics
posted 22/03/2013
Currently, many governments have introduced austerity reforms to control pharmaceutical expenditure. In Austria, efforts have... |
General
The biggest drug patent losses for 2013
posted 17/05/2013
During 2012–2018 over US$290 billion of sales are at risk from patent expirations. In fact, in 2013 alone patents will... 
Indian FDA wants to increase use of generics
posted 03/05/2013
The Commissioner of Indian Food and Drug Administration (FDA) has denied allegations by physicians and pharmacists in India t... 
Generics applications under review by EMA – 2013 Q1
posted 30/04/2013
Last update: 29 April 2013 Generic medicines in Europe can be approved either centrally via EMA or nationally via...
FDA is dragging its feet over oxycodone generics
posted 29/04/2013
The US patent for Purdue Pharma’s (Purdue’s) blockbuster painkiller OxyContin (oxycodone) expired on 16 April 2013, but FDA h... 
Why choose generic medicines initiative launched in Australia
posted 29/03/2013
The Australian Generic Medicines Industry Association (GMiA) and the Pharmacy Guild of Australia announced on 22 March 2013 t... |
Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!
Generics
General
News
- Sanofi fined for discouraging generic clopidogrel prescriptions
- FDA rejects Endo petition to stop Opana ER generics
Research
Generics News Research General
- Sanofi fined for discouraging generic clopidogr...Generics/News | Posted 17/05/2013
- FDA rejects Endo petition to stop Opana ER gene...Generics/News | Posted 17/05/2013
- The biggest drug patent losses for 2013Generics/General | Posted 17/05/2013
- Innovation in the generics industryGenerics/Research | Posted 10/05/2013
Biosimilars News Research General
- Agila Biotech and Pfenex make biosimilars dealBiosimilars/News | Posted 17/05/2013
- Sanofi starts biosimilar insulin trialsBiosimilars/News | Posted 10/05/2013
- Intas launches rituximab ‘similar biologic’ in...Biosimilars/News | Posted 10/05/2013
- Biosimilars approved in EuropeBiosimilars/General | Posted 08/07/2011